SCHEMBL19823047

SCHEMBL19823047

[O-][S+]1CCN(Cc2ccc(-c3c[nH]c4ncccc34)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 5/20 0.49
CAMKK2 Q96RR4 2/20 0.47
OPRM1 P35372 1/20 0.46
HTR2A P28223 3/20 0.45
MAP3K11 Q16584 2/20 0.45
MAP3K9 P80192 1/20 0.45
DRD4 P21917 3/20 0.45
DRD2 P14416 2/20 0.45
DRD3 P35462 2/20 0.45
ROCK2 O75116 3/20 0.44
PIM1 P11309 3/20 0.44
PRKACA P17612 3/20 0.44
CDK2 P24941 3/20 0.44
GSK3B P49841 3/20 0.44
HIPK2 Q9H2X6 3/20 0.44
IRAK4 Q9NWZ3 3/20 0.44
CDC7 O00311 2/20 0.44
HTR7 P34969 2/20 0.44
HTR6 P50406 2/20 0.44
MAP4K4 O95819 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19823045 0.87 TNIK (0.54) TNIKCAMKK2OPRM1HTR2AMAP3K11
SCHEMBL19823067 0.84 TNIK (0.68) TNIKMAP3K11MAP3K9ROCK2CDK2
SCHEMBL19823044 0.84 LRRK2 (0.59) TNIKCAMKK2OPRM1HTR2ADRD4
SCHEMBL19823109 0.83 TNIK (0.53) TNIKCAMKK2OPRM1HTR2AMAP3K11
SCHEMBL19823108 0.83 IKBKB (0.51) PRKACAMAP4K4DYRK1BCLK4DAPK3
SCHEMBL19823048 0.82 TNIK (0.52) TNIKCAMKK2OPRM1HTR2AMAP3K11
SCHEMBL21044844 0.77 CAMKK2 (0.54) TNIKCAMKK2ROCK2PIM1PRKACA
SCHEMBL31258374 0.75 CNR2 (0.55) TNIKCAMKK2OPRM1HTR2ADRD4
SCHEMBL14620845 0.73 CAMKK2 (0.62) CAMKK2ROCK2PIM1PRKACACDK2
SCHEMBL858766 0.72 CAMKK2 (0.64) CAMKK2ROCK2PIM1PRKACACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3492469-A1 COMPOUND AS SELECTIVE JAK INHIBITOR, AND SALT AND THERAPEUTIC USE THEREOF Tianjin Longbogene Pharmaceutical Co., Ltd. (CN) 2019-06-05 EP disclosed
WO-2018019223-A1 COMPOUND AS SELECTIVE JAK INHIBITOR, AND SALT AND THERAPEUTIC USE THEREOF 张文燕 2018-02-01 WO disclosed